ANDA 213834, held by Unichem. Phenytoin Sodium.
As of Nov 16, 2026, ANDA 213834 (Extended Phenytoin Sodium), held by Unichem, was first approved by FDA on Oct 13, 2022, with 0 approved supplements and 0 published complete response letters.
Extended phenytoin sodium capsules are indicated for the treatment of tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 13, 2022 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Extended Phenytoin Sodium100MG EXTENDED · capsule;oral | Phenytoin Sodium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters